Steroid-Induced Hyperglycemia and Its Effect on Outcomes of R-CHOP Chemotherapy for Diffuse Large B-Cell Lymphoma
Large doses of steroids are integral to R-CHOP, a first-line systemic therapy for diffuse large B-cell lymphoma (DLBCL), an aggressive form of non-Hodgkin Lymphoma (NHL). Patients on R-CHOP often develop clinically significant hyperglycemia from steroids. There is evidence of harms from steroid-indu...
Main Authors: | Mark Kristjanson, Pascal Lambert, Kathleen M. Decker, Sonja Bruin, Elizabeth Tingey, Pamela Skrabek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/30/12/738 |
Similar Items
-
Association between sex steroid hormones and subsequent hyperglycemia during pregnancy
by: Ying Meng, et al.
Published: (2023-09-01) -
Management of Glucocorticoid-Induced Hyperglycemia
by: Shah P, et al.
Published: (2022-05-01) -
Comparison of two protocols in the management of glucocorticoid-induced hyperglycemia among hospitalized patients
by: Om J Lakhani, et al.
Published: (2017-01-01) -
Association between the Duration of Steroid Therapy with Hyperglycemia in Patients with Systemic Lupus Erythematosus (SLE)
by: Farahdiva Audrey Widyanrika, et al.
Published: (2024-01-01) -
Influence of Hyperglycemia on the Prognosis of Patients with Diffuse Large B-Cell Lymphoma
by: Zhou W, et al.
Published: (2022-07-01)